• Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, P. R. China;
SUN Bei, Email: sunbei70@tom.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate feasibility and clinical application value of laparoscopic spleen-preserving distal pancreatectomy (LSPDP). Method  The clinical data of 17 patients underwent LSPDP from January 2015 to June 2017 in this hospital were retrospectively analyzed. Results  The LSPDP was successfully completed in the 17 cases, with Kimura procedure and Warshaw procedure were performed in the 12 cases and 5 cases, respectively. The operative time was (218±60) min, the intraoperative blood loss was (136±114) mL, the time to get out of bed after surgery was (1.4±0.6) d, the postoperative fasting time was (2.0±0.8) d, and the postoperative hospital stay was (13.4±5.7) d. The rate of the postoperative pancreatic fistula was 17.6% (3/17). The spleen infarction occurred in the 2 cases following the Warshaw procedure. The pathologic examination showed that there were 2 patients with the serous cystadenoma, 7 patients with the mucinous cystadenoma, 3 patients with the solid pseudo-papillary tumor, 3 patients with the intraductal papillary mucinous cystadenoma neoplasm, and 2 patients with the insulinoma. All the patients were followed-up for 5 to 26 months (average 13 months), and the perigastric varice occurred in 1 patient, no recurrence or spleen infarction occurred during the following-up. Conclusion  LSPDP is a safe, feasible and effective method with less injury and rapid recovery.

Citation: LI Zhonghui, CHEN Hua, CHEN Hongze, SUN Bei. Laparoscopic spleen-preserving distal pancreatectomy: a report of 17 cases. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2018, 25(8): 929-933. doi: 10.7507/1007-9424.201801025 Copy

  • Previous Article

    Expression of miR-106a-5p in gastric cancer cells and gastric cancer tissue and analysis of enriched pathway of target genes
  • Next Article

    Operative safety of HIV-infected patients with colorectal cancer